SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-24-000135
Filing Date
2024-02-06
Accepted
2024-02-06 08:47:49
Documents
15
Period of Report
2024-02-01
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K novaccess20240205_8k.htm   iXBRL 8-K 25514
  Complete submission text file 0001185185-24-000135.txt   162485

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA xsnx-20240201.xsd EX-101.SCH 3229
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xsnx-20240201_def.xml EX-101.DEF 10599
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE xsnx-20240201_lab.xml EX-101.LAB 19947
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xsnx-20240201_pre.xml EX-101.PRE 10961
17 EXTRACTED XBRL INSTANCE DOCUMENT novaccess20240205_8k_htm.xml XML 2733
Mailing Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023
Business Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023 (213) 642-9268
NovAccess Global Inc. (Filer) CIK: 0001039466 (see all company filings)

IRS No.: 841384159 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-29621 | Film No.: 24598225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)